Invus Global Management, LLC → Yarrow Bioscience, Inc. YARW

Stake: — Shares: — Class: Common Stock, $0.0001 par value

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

2 transactions

2 buys · 0 sales · 0 awards/exercises

Issuer Cluster

6 13D/G filings on this issuer

5 other filings besides this one

Filer Track Record

3 filings by this filer

2 other filings in the data moat

Short Interest · settle 2026-09-30

DTC 1.20

189,586 shares short · +49.8% vs prior

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-07-27	Ashiya Mona	director	Award	15,435	$28.56	$441K
2026-07-27	Zeronda Tyler	director	Award	185,798	$28.56	$5.31M

Other 13D/G Filings on Yarrow Bioscience, Inc.

Filed	Form	Filer	Stake	Shares
2026-10-07	SCHEDULE 13G	Bellevue Group AG	—	—	view →
2026-08-14	SCHEDULE 13G	ADAR1 Capital Management, LLC	—	—	view →
2026-08-05	SCHEDULE 13D	ORBIMED ADVISORS LLC	9.97%	266,306	view →
2026-07-29	SCHEDULE 13D/A	AI Biotechnology LLC	6.02%	178,180	view →
2020-04-16	SC	venBio Global Strategic Fund II L.P.	—	—	view →

Other Filings by Invus Global Management, LLC

Filed	Form	Issuer	Stake	Shares
2026-07-17	SCHEDULE 13G	Agenus Inc.	—	—	view →
2026-06-15	SCHEDULE 13G	Eloxx Pharmaceuticals, Inc. ELOX	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →